Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Baker

Showing results (11-20 of 245) with videos related to

Pageof 25
Sort By:
Arthritis Care & Research|June 1, 2020
Defining Minimum Clinically Important Changes for the Patient Activity Scale IIJoshua F Baker, Patti Katz, Kaleb Michaud
Arthritis Care & Research|October 17, 2022
ReplyJoshua F Baker, George Reed, Joel Kremer
Arthritis Care & Research|October 1, 2020
Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid ArthritisJoshua F Baker, George Reed, Joel Kremer
Arthritis Care & Research|April 3, 2025
Metabolic Consequences of Rheumatoid ArthritisStevie Barry, Emily Sheng, Joshua F Baker
Rheumatic Diseases Clinics of North America|November 4, 2022
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid ArthritisNancy Desai, Lydia Federico, Joshua F Baker
Clinical and Experimental Rheumatology|October 10, 2018
Update on magnetic resonance imaging and ultrasound in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Frederique Gandjbakhch
ACR Open Rheumatology|September 28, 2020
Physical Activity Patterns in People With Inflammatory Arthritis Indicate They Have not Received Recommendation-Based Guidance From Health Care ProvidersLauren M Freid, Alexis Ogdie, Joshua F Baker
The Journal of Rheumatology|September 3, 2019
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisMichael D George, Joshua F Baker, Alexis Ogdie
Current Rheumatology Reports|August 3, 2020
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid ArthritisDilli Poudel, Michael D George, Joshua F Baker
Clinical and Experimental Rheumatology|July 29, 2014
Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndromeGhaith Noaiseh, Joshua F Baker, Frederick B Vivino
Pageof 25

Showing results (11-20 of 245) with videos related to

Sort By:
Pageof 25
Arthritis Care & Research|June 1, 2020
Defining Minimum Clinically Important Changes for the Patient Activity Scale IIJoshua F Baker, Patti Katz, Kaleb Michaud
Arthritis Care & Research|October 17, 2022
ReplyJoshua F Baker, George Reed, Joel Kremer
Arthritis Care & Research|October 1, 2020
Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid ArthritisJoshua F Baker, George Reed, Joel Kremer
Arthritis Care & Research|April 3, 2025
Metabolic Consequences of Rheumatoid ArthritisStevie Barry, Emily Sheng, Joshua F Baker
Rheumatic Diseases Clinics of North America|November 4, 2022
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid ArthritisNancy Desai, Lydia Federico, Joshua F Baker
Clinical and Experimental Rheumatology|October 10, 2018
Update on magnetic resonance imaging and ultrasound in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Frederique Gandjbakhch
ACR Open Rheumatology|September 28, 2020
Physical Activity Patterns in People With Inflammatory Arthritis Indicate They Have not Received Recommendation-Based Guidance From Health Care ProvidersLauren M Freid, Alexis Ogdie, Joshua F Baker
The Journal of Rheumatology|September 3, 2019
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisMichael D George, Joshua F Baker, Alexis Ogdie
Current Rheumatology Reports|August 3, 2020
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid ArthritisDilli Poudel, Michael D George, Joshua F Baker
Clinical and Experimental Rheumatology|July 29, 2014
Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndromeGhaith Noaiseh, Joshua F Baker, Frederick B Vivino
Pageof 25